| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Patricio Alb. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics]. Vertex (Buenos Aires, Argentina). vol 28. issue 132. 2018-12-11. PMID:29522636. |
[treatment-resistant schizophrenia: neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics]. |
2018-12-11 |
2023-08-13 |
Not clear |
| John Lally, Hana Al Kalbani, Amir Krivoy, Kieran C Murphy, Fiona Gaughran, James H MacCab. Hepatitis, Interstitial Nephritis, and Pancreatitis in Association With Clozapine Treatment: A Systematic Review of Case Series and Reports. Journal of clinical psychopharmacology. vol 38. issue 5. 2018-12-11. PMID:30059436. |
clozapine is the criterion standard in treatment-resistant schizophrenia. |
2018-12-11 |
2023-08-13 |
Not clear |
| Carolyn B McNabb, Roger J Tait, Meghan E McIlwain, Valerie M Anderson, John Suckling, Robert R Kydd, Bruce R Russel. Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia. Schizophrenia research. vol 195. 2018-11-26. PMID:29042073. |
resting-state functional mri data were obtained from 17 healthy controls as well as individuals with schizophrenia who responded well to first-line atypical antipsychotics (first-line responders; flr, n=18), had failed at least two trials of antipsychotics but responded to clozapine (treatment-resistant schizophrenia; trs, n=18), or failed at least two trials of antipsychotics and a trial of clozapine (ultra-treatment-resistant schizophrenia; utrs, n=16). |
2018-11-26 |
2023-08-13 |
Not clear |
| Fatemeh Behdani, Seyede Narjes Roudbaraki, Maryam Saberi-Karimian, Maryam Tayefi, Paria Hebrani, Amir Akhavanrezayat, Sadegh Vahabi Amlashi, Gordon A Ferns, Majid Ghayour-Mobarha. Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate. Psychiatry research. vol 261. 2018-11-20. PMID:29329042. |
assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate. |
2018-11-20 |
2023-08-13 |
human |
| Fatemeh Behdani, Seyede Narjes Roudbaraki, Maryam Saberi-Karimian, Maryam Tayefi, Paria Hebrani, Amir Akhavanrezayat, Sadegh Vahabi Amlashi, Gordon A Ferns, Majid Ghayour-Mobarha. Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate. Psychiatry research. vol 261. 2018-11-20. PMID:29329042. |
we aimed to assess the efficacy of omega-3 fatty acids on metabolic and inflammatory indices in patients with schizophrenia who were taking clozapine and sodium valproate. |
2018-11-20 |
2023-08-13 |
human |
| Fatemeh Behdani, Seyede Narjes Roudbaraki, Maryam Saberi-Karimian, Maryam Tayefi, Paria Hebrani, Amir Akhavanrezayat, Sadegh Vahabi Amlashi, Gordon A Ferns, Majid Ghayour-Mobarha. Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate. Psychiatry research. vol 261. 2018-11-20. PMID:29329042. |
our results showed omega-3 fa supplementation can improve some anthropometric indices in patients with schizophrenia who are taking clozapine pharmacotherapy. |
2018-11-20 |
2023-08-13 |
human |
| Marise W J Machielsen, Dick J Veltman, Wim van den Brink, Lieuwe de Haa. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study. Schizophrenia research. vol 194. 2018-11-13. PMID:28351544. |
comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: a randomized fmri study. |
2018-11-13 |
2023-08-13 |
Not clear |
| Narjes Hendouei, Samaneh Farnia, Farhad Mohseni, Azadeh Salehi, Maedeh Bagheri, Faezeh Shadfar, Fatemeh Barzegar, Seyed Davood Hoseini, Jamshid Yazdani Charati, Fatemeh Shak. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 103. 2018-11-13. PMID:29710513. |
therefore, in this study, we evaluated the level of oxidative stress parameters between patients treated with perphenazine, clozapine and risperidone and their relationship with schizophrenia symptoms' severity. |
2018-11-13 |
2023-08-13 |
Not clear |
| Pushpal Desarkar, Daniel Blumberger, Zafiris Jeff Daskalaki. Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability. Journal of autism and developmental disorders. vol 48. issue 10. 2018-11-07. PMID:29696528. |
case report: successful use of the combination of electroconvulsive therapy and clozapine in treating treatment-resistant schizophrenia and catatonia in an adult with intellectual disability. |
2018-11-07 |
2023-08-13 |
Not clear |
| Pushpal Desarkar, Daniel Blumberger, Zafiris Jeff Daskalaki. Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability. Journal of autism and developmental disorders. vol 48. issue 10. 2018-11-07. PMID:29696528. |
there is paucity of empirical data regarding the use of either clozapine or electroconvulsive therapy (ect) in the acute phase and maintenance treatment of schizophrenia in adults with intellectual disability. |
2018-11-07 |
2023-08-13 |
Not clear |
| Pushpal Desarkar, Daniel Blumberger, Zafiris Jeff Daskalaki. Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability. Journal of autism and developmental disorders. vol 48. issue 10. 2018-11-07. PMID:29696528. |
herein we report the successful acute and long-term remission of psychotic symptoms and catatonia with the combination of clozapine and ect in a 26-year-old female with moderate id and treatment-resistant schizophrenia. |
2018-11-07 |
2023-08-13 |
Not clear |
| Pushpal Desarkar, Daniel Blumberger, Zafiris Jeff Daskalaki. Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability. Journal of autism and developmental disorders. vol 48. issue 10. 2018-11-07. PMID:29696528. |
to our knowledge, this is the first case example of the successful use of the combination of bilateral, standard-pulse ect and clozapine in both acute and long-term treatment of treatment-resistant schizophrenia and catatonia in an adult with id. |
2018-11-07 |
2023-08-13 |
Not clear |
| Heidi J Wehring, Teresa Elsobky, Joseph P McEvoy, Gopal Vyas, Charles M Richardson, Robert P McMahon, Bethany A DiPaula, Fang Liu, Kelli Sullivan, Robert W Buchanan, Stephanie Feldman, Elizabeth M McMahon, Deanna L Kell. Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels. The Psychiatric quarterly. vol 89. issue 1. 2018-11-05. PMID:28466366. |
adjunctive minocycline in clozapine-treated patients with schizophrenia: analyzing the effects of minocycline on clozapine plasma levels. |
2018-11-05 |
2023-08-13 |
human |
| Heidi J Wehring, Teresa Elsobky, Joseph P McEvoy, Gopal Vyas, Charles M Richardson, Robert P McMahon, Bethany A DiPaula, Fang Liu, Kelli Sullivan, Robert W Buchanan, Stephanie Feldman, Elizabeth M McMahon, Deanna L Kell. Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels. The Psychiatric quarterly. vol 89. issue 1. 2018-11-05. PMID:28466366. |
clozapine is the sole antipsychotic agent effective for the treatment of refractory schizophrenia. |
2018-11-05 |
2023-08-13 |
human |
| Heidi J Wehring, Teresa Elsobky, Joseph P McEvoy, Gopal Vyas, Charles M Richardson, Robert P McMahon, Bethany A DiPaula, Fang Liu, Kelli Sullivan, Robert W Buchanan, Stephanie Feldman, Elizabeth M McMahon, Deanna L Kell. Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels. The Psychiatric quarterly. vol 89. issue 1. 2018-11-05. PMID:28466366. |
this is a secondary analysis of a 10-week controlled study of adjunctive minocycline to clozapine in treatment refractory schizophrenia. |
2018-11-05 |
2023-08-13 |
human |
| Kathleen Patchan, Gopal Vyas, Ann L Hackman, Marie Mackowick, Charles M Richardson, Raymond C Love, Ikwunga Wonodi, MacKenzie A Sayer, Matthew Glassman, Stephanie Feldman, Deanna L Kell. Clozapine in Reducing Aggression and Violence in Forensic Populations. The Psychiatric quarterly. vol 89. issue 1. 2018-11-05. PMID:28643049. |
this paper reviews violence and incarceration in individuals with schizophrenia as well as recommendations, guidelines and benefits for the use of clozapine in this population. |
2018-11-05 |
2023-08-13 |
Not clear |
| Amir Krivoy, Eldar Hochman, Kyra-Verena Sendt, Sarah Hollander, Yael Vilner, Mirjana Selakovic, Abraham Weizman, Michal Tale. Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment. Schizophrenia research. vol 192. 2018-10-31. PMID:28599751. |
clozapine is the only available therapy for about 30% of schizophrenia patients otherwise refractory to antipsychotics. |
2018-10-31 |
2023-08-13 |
Not clear |
| Amir Krivoy, Eldar Hochman, Kyra-Verena Sendt, Sarah Hollander, Yael Vilner, Mirjana Selakovic, Abraham Weizman, Michal Tale. Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment. Schizophrenia research. vol 192. 2018-10-31. PMID:28599751. |
blood samples of 89 chronic schizophrenia patients maintained on clozapine were analyzed in a cross-sectional design. |
2018-10-31 |
2023-08-13 |
Not clear |
| Aleksandra Margulska, Elżbieta Kozłowska, Adam Wysokińsk. Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides. Psychiatry research. vol 260. 2018-10-31. PMID:29275180. |
serum concentration of clozapine and fasting serum levels of des-acylated ghrelin, neuropeptide y (npy), agouti-related protein (agrp), peptide yy (pyy(1-36)), cocaine- and amphetamine-regulated transcript (cart), leptin and obestatin were measured in 30 subjects with schizophrenia on clozapine monotherapy. |
2018-10-31 |
2023-08-13 |
human |
| Iris E C Sommer, Hidde Kleijer, Lucy Visser, Teus van Laa. Successful treatment of intractable visual hallucinations with 5-HT BMJ case reports. vol 2018. 2018-10-31. PMID:29950360. |
we present a patient with schizophrenia with intractable hallucinations despite state of the art care, including high-dose clozapine and transcranial magnetic stimulation. |
2018-10-31 |
2023-08-13 |
Not clear |